Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

Efficacy and hypoglycemia outcomes with once-weekly IcoSema vs comparators in T2D by baseline BMI: COMBINE 1-3

Authors :

Daisuke Yabe¹; Raluca Maltesen²; Viswanathan Mohan³; Laura Pletsch-Borba⁴; Cathrine Scavenius⁴; Linong Ji⁵

Affiliations

View Details Hide Details

Download .PDF

Keywords

Diabetes

Congress poster

Amylin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)